Health Care News – Read More Anti-abortion voices are growing increasingly impatient for the Trump administration to complete a review of the abortion pill mifepristone, potentially altering its approval. But changing abortion access at the federal level could imperil an already vulnerable GOP in the upcoming midterms. While on the campaign trail, President Trump played his cards close to the…